Dyne Therapeutics, Inc.
NASDAQ · us_market
No AI insight generated yet for this ticker.
Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. The company is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. Dyne Therapeutics, Inc. was incorporated in 2017 and is headquartered in Waltham, Massachusetts.
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| FidelityFMR | fundamental | 8.91M | $161.52M | 0.01% | Added+35.6% | 2026-03-31 |
| StateStreet | passive | 6.65M | $120.63M | 0.00% | Trimmed-0.6% | 2026-03-31 |
| RenTech | quant | 533.6K | $9.67M | 0.02% | Added+13.4% | 2026-03-31 |
| Wellington | fundamental | 48.9K | $886.23K | 0.00% | Added+3.8% | 2026-03-31 |
| TRowePrice | fundamental | 2.33M | $42.22K | 0.00% | Unchanged | 2026-03-31 |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-07-27upcoming | -0.75 | — | — |
| 2026-05-11 | -0.78 | -0.73 | +6.65% |
| 2026-03-02 | -0.76 | -0.73 | +4.41% |
| 2025-11-05 | -0.85 | -0.76 | +10.08% |
| 2025-07-28 | -0.93 | -0.97 | -3.92% |
| 2025-05-08 | -0.84 | -1.05 | -25.54% |
| 2025-02-27 | -0.91 | -0.88 | +3.51% |
| 2024-11-12 | -0.71 | -0.96 | -34.95% |
| 2024-08-12 | -0.72 | -0.70 | +2.71% |
| 2024-05-02 | -0.81 | -0.81 | +0.25% |
| 2024-03-05 | -0.93 | -1.09 | -17.15% |
| 2023-10-30 | -0.76 | -0.99 | -29.76% |
| 2023-08-03 | -0.78 | -1.08 | -37.78% |
| 2023-05-11 | -0.76 | -0.78 | -2.09% |
| 2023-03-02 | -0.84 | -0.74 | +11.88% |
| 2022-11-03 | -0.92 | -0.80 | +13.42% |
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| DYN | +11.16% | +32.40% | -1.18% | +61.62% |
| XLV | +2.97% | -4.64% | -3.44% | +12.69% |
| Alpha (stock − sector) | +8.19% | +37.04% | +2.27% | +48.93% |